Literature DB >> 27922865

Additional Value of Early-Phase 18F-FP-CIT PET Image for Differential Diagnosis of Atypical Parkinsonism.

Soyoung Jin1, Minyoung Oh, Seung Jun Oh, Jungsu S Oh, Sang Ju Lee, Sun Ju Chung, Jae Seung Kim.   

Abstract

PURPOSE: Regional cerebral perfusion is coupled to metabolism in general. Early perfusion dominant imaging using F-FP-CIT PET (pCIT) may provide complementary information to delayed dopamine transporter dominant images. We investigated the ability of pCIT to differentiate atypical Parkinson disorder from Parkinson disease (PD) compared to FDG and the image quality for optimizing the acquisition time.
METHODS: Sixty-seven subjects [PD, 23 subjects; multiple system atrophy-cerebellar type (MSA-C), 27 subjects; MSA-Parkinson type (MSA-P), 12 subjects; and progressive supranuclear palsy (PSP), 5 subjects] underwent F-FP-CIT and FDG PET. Using dynamic PET data acquired during the first 10 minutes after F-FP-CIT administration, we generated potential perfusion images of 0 to 5 (pCIT-5m), 0 to 7 (pCIT-7m), and 0 to 10 (pCIT-10m) minutes. We compared regional uptake between groups in pCIT and FDG images and image quality among pCIT images using visual, quantitative, or statistical parametric mapping analyses.
RESULTS: Regional cerebral uptake of pCITs correlated well to that of the FDG images (R > 0.5, all). Multiple system atrophy-cerebellar type and MSA-P groups show different regional uptake patterns compared with PD group on pCITs in quantitative and statistical parametric mapping analyses, analogous to FDG images, but not in the PSP group. In visual analysis, concordance rates between each pCIT and FDG image were high (92.3%-96.0%, regional; 86.2%-93.1%, diagnostic), and there was no significant difference among pCITs. However, pCIT-10m discriminated PSP better than others and showed higher signal-to-noise ratio (P = 0.001).
CONCLUSION: F-FP-CIT PETs with the first 10 minutes could be useful for the differential diagnosis of atypical Parkinson disorder by providing complementary FDG-like information to the dopamine transporter binding on late-phase FP-CIT images.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27922865     DOI: 10.1097/RLU.0000000000001474

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  14 in total

1.  Dual-phase 18F-FP-CIT PET in corticobasal syndrome underlying AD pathology.

Authors:  Jung Han Yoon; Young Sil Ahn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-04       Impact factor: 9.236

2.  Early- and late-phase 18F-FP-CIT PET images in vascular parkinsonism due to midbrain infarct.

Authors:  Song Hwangbo; Yooha Hong; Sang Won Choi; Joo Yong Kim; You Mie Han; Suk Yun Kang
Journal:  Neurol Sci       Date:  2018-12-07       Impact factor: 3.307

Review 3.  Early perfusion and dopamine transporter imaging using 18F-FP-CIT PET/CT in patients with parkinsonism.

Authors:  Chae-Moon Hong; Ho-Sung Ryu; Byeong-Cheol Ahn
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-12-20

Review 4.  60 Years of Achievements by KSNM in Neuroimaging Research.

Authors:  Jae Seung Kim; Hye Joo Son; Minyoung Oh; Dong Yun Lee; Hae Won Kim; Jungsu Oh
Journal:  Nucl Med Mol Imaging       Date:  2022-01-15

5.  Diagnostic Performance for Differential Diagnosis of Atypical Parkinsonian Syndromes from Parkinson's Disease Using Quantitative Indices of 18F-FP-CIT PET/CT.

Authors:  Miju Cheon; Seung Min Kim; Sang-Won Ha; Min Ju Kang; Hea-Eun Yang; Jang Yoo
Journal:  Diagnostics (Basel)       Date:  2022-06-06

6.  Multimodal correlation of dynamic [18F]-AV-1451 perfusion PET and neuronal hypometabolism in [18F]-FDG PET.

Authors:  Jochen Hammes; Isabel Leuwer; Gérard N Bischof; Alexander Drzezga; Thilo van Eimeren
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-10-12       Impact factor: 9.236

7.  Correlation of Early-Phase F-18 Florapronal PET with F-18 FDG PET in Alzheimer's Disease and Normal Brain.

Authors:  Jieun Jeong; Young Jin Jeong; Kyung Won Park; Do-Young Kang
Journal:  Nucl Med Mol Imaging       Date:  2019-09-11

8.  Spatial Normalization Using Early-Phase [18F]FP-CIT PET for Quantification of Striatal Dopamine Transporter Binding.

Authors:  Sungwoo Bae; Hongyoon Choi; Wonseok Whi; Jin Chul Paeng; Gi Jeong Cheon; Keon Wook Kang; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2020-10-13

9.  Dynamic 18F-FPCIT PET: Quantification of Parkinson's disease metabolic networks and nigrostriatal dopaminergic dysfunction in a single imaging session.

Authors:  Shichun Peng; Chris Tang; Katharina Schindlbeck; Yaacov Rydzinski; Vijay Dhawan; Phoebe G Spetsieris; Yilong Ma; David Eidelberg
Journal:  J Nucl Med       Date:  2021-03-19       Impact factor: 11.082

10.  Diagnostic accuracy of dual-phase 18F-FP-CIT PET imaging for detection and differential diagnosis of Parkinsonism.

Authors:  Minyoung Oh; Narae Lee; Chanwoo Kim; Hye Joo Son; Changhwan Sung; Seung Jun Oh; Sang Ju Lee; Sun Ju Chung; Chong Sik Lee; Jae Seung Kim
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.